Related Experiment Video
Updated: Feb 9, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Is there a role for immunotherapy in malignant pleural mesothelioma?
Alfredo Tartarone1, Rosa Lerose2, Michele Aieta3
1Department of Onco-Hematology, Unit of Medical Oncology, IRCCS-CROB Referral Cancer Center of Basilicata, Rionero in Vulture, PZ, Italy. tarta1@virgilio.it.
Abstract:
Malignant pleural mesothelioma (MPM) is a very aggressive malignancy, mainly caused by asbestos exposure. Patients with MPM have a poor prognosis that remained substantially unchanged in the last few years and limited effective therapeutic options with no recognized second or further-line therapy. In this context, also in view of the positive results observed in other tumor types, immunotherapy could play a relevant role. This review focuses on the most promising immunotherapies being investigated in MPM.
Insights
Malignant pleural mesothelioma (MPM) is an aggressive cancer with poor prognosis. This review explores promising immunotherapies as potential new treatments for MPM patients.
Area of Science:
- Oncology
- Immunology
Background:
- Malignant pleural mesothelioma (MPM) is a highly aggressive cancer.
- Asbestos exposure is the primary cause of MPM.
- Current therapeutic options for MPM are limited, with no standard second-line treatments.
Purpose of the Study:
- To review the most promising immunotherapies for malignant pleural mesothelioma.
- To highlight the potential role of immunotherapy in improving MPM outcomes.
Main Methods:
- Literature review of preclinical and clinical studies on immunotherapy in MPM.
- Focus on emerging immunotherapeutic strategies and their mechanisms of action.
Main Results:
- Immunotherapy has shown promise in other cancer types.
- Several immunotherapeutic agents are under investigation for MPM.
- Early results suggest potential efficacy, but further research is needed.
Conclusions:
- Immunotherapy represents a promising avenue for novel MPM treatment strategies.
- Further clinical investigation is crucial to establish the role of immunotherapy in MPM management.
Related Concept Videos
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
Tumor Immunotherapy
Pleural Disorders: Types and Brief Description
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Role of Septins
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...
The Role of Culture

